Drugging the Next Undruggable KRAS Allele-Gly12Asp

被引：24
|
作者：
Zheng, Qinheng [1 ]
Peacock, D. Matthew [1 ]
Shokat, Kevan M. [1 ]
机构：
[1] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2022年 / 65卷 / 04期
关键词：
K-RAS; BIND;
D O I：
10.1021/acs.jmedchem.2c00099
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Since its discovery as the first human oncogene in 1983, the small GTPase KRAS has been a major target of cancer drug discovery. The paper reported in this issue describes a long-awaited small molecule drug candidate of the oncogenic KRAS (G12D) mutant for the treatment of currently incurable pancreatic cancer.
引用
收藏
页码：3119 / 3122
页数：4
相关论文
共 50 条
  • [21] Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
    Lito, Piro
    Solomon, Martha
    Hansen, Rasmus
    Li, Lian-Sheng
    Rosen, Neal
    CANCER RESEARCH, 2016, 76
  • [22] Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
    Lito, Piro
    Solomon, Martha
    Hansen, Rasmus
    Li, Lian-Sheng
    Rosen, Neal
    CANCER RESEARCH, 2016, 76
  • [23] Immobilization of Arg-Gly-Asp (RGD) sequence in sugar containing copolymer for culturing of pheochromocytoma (PC 12) cells
    Park, KH
    Na, K
    Lee, KC
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2004, 97 (03) : 207 - 211
  • [24] Characterisation of a novel KRAS G12C inhibitor ASP2453 that shows potent anti-tumour activity in KRAS G12C-mutated preclinical models
    Nakayama, Ayako
    Nagashima, Takeyuki
    Nishizono, Yoshihiro
    Kuramoto, Kazuyuki
    Mori, Kenichi
    Homboh, Kazuya
    Yuri, Masatoshi
    Shimazaki, Masashi
    BRITISH JOURNAL OF CANCER, 2022, 126 (05) : 744 - 753
  • [25] A Gly823→Asp mutation in the Finnish familial hypercholesterolemia (FH)-Turku allele of the LDL receptor gene affects polarized sorting of LDL receptors
    Kolvisto, UM
    Mellman, IS
    CIRCULATION, 1999, 100 (18) : 689 - 689
  • [26] Zellweger spectrum disorder patient-derived fibroblasts with the PEX1-Gly843Asp allele recover peroxisome functions in response to flavonoids
    MacLean, Gillian E.
    Argyriou, Catherine
    Di Pietro, Erminia
    Sun, Xuting
    Birjandian, Sara
    Saberian, Panteha
    Hacia, Joseph G.
    Braverman, Nancy E.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 3243 - 3258
  • [27] Characterisation of a novel KRAS G12C inhibitor ASP2453 that shows potent anti-tumour activity in KRAS G12C-mutated preclinical models
    Ayako Nakayama
    Takeyuki Nagashima
    Yoshihiro Nishizono
    Kazuyuki Kuramoto
    Kenichi Mori
    Kazuya Homboh
    Masatoshi Yuri
    Masashi Shimazaki
    British Journal of Cancer, 2022, 126 : 744 - 753
  • [28] Combination effect of the KRAS G12D-specific degrader ASP3082 with Cetuximab in xenograft models of colorectal and pancreatic cancer cells with KRAS G12D mutation
    Iguchi, K.
    Nagashima, T.
    Inamura, K.
    Nishizono, Y.
    Yoshinari, T.
    Hayakawa, M.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S86 - S86
  • [29] ASP3082, a First-in-class novel KRAS G12D degrader, exhibits remarkable anti-tumor activity in KRAS G12D mutated cancer models
    Nagashima, T.
    Inamura, K.
    Nishizono, Y.
    Suzuki, A.
    Tanaka, H.
    Yoshinari, T.
    Yamanaka, Y.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S30 - S30
  • [30] Detection of specific KRAS mutation type, Gly12Asp (GGT>GAT), in EUS-guided fine needle aspiration cytology (EUS-FNAC) identifies pancreatic cancer patients with poor prognosis
    Minarik, Marek
    Halkova, Tereza
    Belsanova, Barbora
    Bunganic, Bohus
    Zavoral, Miroslav
    Benesova, Lucie
    CANCER RESEARCH, 2016, 76
12345